Fritextsökning
Innehållstyper
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Getinge skaffar ny finanschef
Pernille Fabricius sköter ekonomin på medtechbolaget.
-
Mathematician new dean at DTU
On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Apoteksutredning föreslår flera åtgärder för säkerhet
Utredaren Åsa Kullgren föreslår flera förändringar som ska förbättra säkerheten och tillgängligheten på apoteksmarknaden.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Take off for this year's fair
More visitors than previously were preregistered when Scanlab and Biotech Forum opened today. But the future of the exhibitions and their design is uncertain.
-
Polymer guru new dean at DTU
The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.
-
Datorn som matchmaker
Datorbaserade modeller kan användas för att förstå interaktioner mellan två läkemedel eller förutsäga biverkningar. - Det blir också möjligt att identifiera pro...
-
Grönt ljus för indiskt köp
Recipharm får klartecken för köpet av kontraktstillverkaren Nitin.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...
-
KI innovations väljer ut bolag
Efter stöd från Vinnova stärker KI innovations nu sitt inkubatorserbjudande till life sciencebolag. Sex bolag har valts ut till inkubatorsprogrammet.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Woman deficit in Swedish research
The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.
-
New CEO to Medivir
The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Stärker säljteamet
Anke Mollowitz sköter Recipharms europeiska kunder.
-
Så kan kapital frigöras i vården
Med en mer effektiv användning av kapitalet i svensk sjukvård kan nödvändiga investeringar möjliggöras, skriver Carl Ahlgren, Siemens Financial Services.
-
Sectra får stororder
Tecknar avtal med Karolinska sjukhuset till ett värde om 207 miljoner.
-
Hon tar plats på SDS
Ann-Kristin Gellerbring är ny Senior Advisor Biologicals på konsultbolaget.
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Researchers goes to the bottom of the brain
Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.
BREAKING